To analyze the impact of adjuvant radiotherapy (RT) on ipsilateral breast recurrence (IBR) and overall survival (OS) in patients older than 69 years with early-stage breast cancer.
Methods:
From January 2007 to June 2015, we analyzed retrospectively 137 women with estrogen receptor–positive T1–2 invasive breast cancer, with negative axillary lymph nodes, dividing them into 2 subgroups: 70 to 79 years and older than 79 years.
Results:
After a median follow-up of 43.2 months, the 3-year IBR-free survival in patients treated with surgery plus RT was 98.8% and 92.1% in patients treated with surgery alone, with a significant difference (p = .01). Radiotherapy did not impact overall survival (p = .10). A higher percentage of patients aged between 70 and 79 years received RT after conservative surgery if compared with the older subgroup (p < .01).
Conclusions:
In elderly women, adjuvant RT reduced the IBR, but did not improve OS.
AriasEHeronMXuJ.United States Life Tables, 2014. Natl Vital Stat Rep2017; 66: 1–64.
3.
MarmotMGAltmanDGCameronDADewarJAThompsonSGWilcoxM.The benefits and harms of breast cancer screening: an independent review. Br J Cancer2013; 108: 2205–2240.
4.
VeronesiUSaccozziRDel VecchioM, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med1981; 305: 6–11.
5.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG),DarbySMcGaleP, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet2011; 378: 1707–1716.
6.
TinterriCGatzemeierWZaniniV, et al. Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: a prospective randomised multicentre trial. Breast2009; 18: 373–377.
7.
KunklerIHWilliamsLJJackWJCameronDADixonJM;PRIME II investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol2015; 16: 266–273.
8.
AudisioRAWyldL.No standard is set for older women with breast cancer. Eur J Surg Oncol2015; 41: 607–609.
9.
FengMMoranJMKoellingT, et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys2011; 79: 10–18.
10.
CharlsonMEPompeiPAlesKL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis1987; 40: 373–383.
11.
HughesKSSchnaperLABellonJR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol2013; 31: 2382–2387.
12.
ChesneyTRXin YinJRajaeeN, et al. Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: a systematic review and meta-analysis. Radiother Oncol2017; 123: 1–9.
13.
AlbertJMPanIWShihYC, et al. Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery. Cancer2012; 118: 4642–4651.
14.
TruongPTBernsteinVLesperanceMSpeersCHOlivottoIA.Radiotherapy omission after breast-conserving surgery was associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg2006; 191: 749–755.
15.
FylesAWMcCreadyDRManchulLA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med2004; 351: 963–970.
16.
BartelinkHMaingonPPoortmansP, et al, on behalf of the European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol2015; 16: 47–56.
17.
FiorentinoAMazzolaRGiaj LevraN, et al. Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients. Aging Clin Exp Res. Epub ahead of print 28 Jul 2017.
18.
WhelanTJPignolJPLevineMN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med2010; 362: 513–520.
19.
BentzenSMAgrawalRKAirdEG, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol2008; 9: 331–341.
20.
BentzenSMAgrawalRKAirdEG, et al. The UK Standardisation of Breast Radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet2008; 371: 1098–1107.
